# Department of Defense - Navy – FDA Inspection, Oct 3, 2024

Source: https://www.keypedia.com/records/fda_inspections/department-of-defense-navy/822aeefe-5851-4f86-b20d-37685ebbe783
Source feed: FDA_Inspections

> FDA inspection 1250935 of Department of Defense - Navy, October 03, 2024. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR parts 606, 610 and 630. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1250935
- Company Name: Department of Defense - Navy
- Inspection Date: 2024-10-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Baltimore District Office
- Citation Count: 4

## Related Documents

- FDA Inspection 1167020 - 2022-03-11
- FDA Inspection 1068540 - 2018-09-20
- FDA Inspection 937758 - 2015-08-06
- [FDA Inspection 847540 - 2013-09-09](https://www.keypedia.com/records/fda_inspections/department-of-defense-navy/cbf07b13-9c45-40ba-bf8a-533130b53480)
- FDA Inspection 722889 - 2011-05-02

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/la-tasha-m-gunter/db9cd9cf-db0a-4c31-9f7c-24760750f34d)

Company: https://www.keypedia.com/companies/department-of-defense-navy/3bd0b93e-7977-4b26-ba2c-2f9688483f20

Office: https://www.keypedia.com/offices/baltimore-district-office/6be371ff-03e9-4039-999c-ff170f17a9fa
